SPDR S&P Biotech ETF (NYSEARCA:XBI) Shares Sold by Letko Brosseau & Associates Inc.

Letko Brosseau & Associates Inc. reduced its stake in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 13.5% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 56,900 shares of the exchange traded fund’s stock after selling 8,900 shares during the period. Letko Brosseau & Associates Inc.’s holdings in SPDR S&P Biotech ETF were worth $5,275,000 as of its most recent SEC filing.

Other hedge funds have also modified their holdings of the company. Avoro Capital Advisors LLC purchased a new stake in SPDR S&P Biotech ETF during the fourth quarter valued at about $396,844,000. Healthcare of Ontario Pension Plan Trust Fund grew its holdings in shares of SPDR S&P Biotech ETF by 30.3% during the 1st quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 3,136,000 shares of the exchange traded fund’s stock worth $297,575,000 after purchasing an additional 730,000 shares during the period. Mirae Asset Securities USA Inc. acquired a new stake in SPDR S&P Biotech ETF during the 2nd quarter worth approximately $55,626,000. Jane Street Group LLC raised its holdings in SPDR S&P Biotech ETF by 68.7% in the first quarter. Jane Street Group LLC now owns 961,082 shares of the exchange traded fund’s stock valued at $91,197,000 after buying an additional 391,333 shares during the period. Finally, Baymount Management LP purchased a new position in SPDR S&P Biotech ETF in the first quarter valued at approximately $34,160,000.

SPDR S&P Biotech ETF Trading Down 1.6 %

XBI traded down $1.56 during trading on Friday, hitting $96.52. 8,019,337 shares of the company’s stock were exchanged, compared to its average volume of 9,875,957. SPDR S&P Biotech ETF has a 1 year low of $63.80 and a 1 year high of $103.52. The stock has a 50 day moving average price of $97.74 and a 200 day moving average price of $93.80. The firm has a market cap of $7.36 billion, a P/E ratio of 11.47 and a beta of 1.11.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.